Bone Histomorphometry in Young Patients With Type 2 Diabetes is Affected by Disease Control and Chronic Complications
Overview
Authors
Affiliations
Context: Type 2 diabetes mellitus (T2DM) is associated with an increased risk of fractures. No study has evaluated the correlation of bone histomorphometry (BH) parameters with glycemic control and presence of chronic complications (CCs) in premenopausal women with T2DM.
Objectives: To evaluate BH and correlate them with the degree of glycemic control and presence of CCs.
Design, Settings, And Patients: This was a cross-sectional study conducted at a tertiary medical center. Twenty-six premenopausal women with T2DM were divided into groups with glycated hemoglobin HbA1c < 7% (good control, GC; n = 10) and HbA1c > 7% (poor control, PC; n = 16), and further subdivided into groups with (n = 9) and without (n = 17) CCs. BH parameters (bone volume [bone volume per total volume, BV/TV], trabecular thickness [Tb.Th], trabecular number [Tb.N], trabecular separation [Tb.Sp], osteoid thickness [O.Th], osteoid surface [osteoid surface per bone surface, OS/BS]), mineralizing surface [MS/BS], bone formation rate [BFR]), mineral apposition rate [MAR]) as well as serum pentosidine (PEN) and insulin-like growth factor (IGF)-1 were measured. The BH data were compared among the groups and with a BH control group (control group, CG, n = 15) matched by age, sex, and race.
Results: BV/TV was increased in GC (P < .001) and PC (P = .05) groups and O.th (P = .03) was smaller in the PC group than in the CG. A comparison of the groups with and without CCs with the CG showed in the group with CCs, O.Th was smaller(P = .01) and BV/TV similar to the CG (P = .11). HbA1c correlated negatively with O.Th (P = .02) and OS/BS (P = .01). There was no correlation of BH to PEN and IGF-1.
Conclusion: BH in premenopausal patients with T2DM is affected by disease control and chronic complications.
Leanza G, Cannata F, Faraj M, Pedone C, Viola V, Tramontana F Elife. 2024; 12.
PMID: 38598270 PMC: 11006415. DOI: 10.7554/eLife.90437.
Vilaca T, Eastell R JBMR Plus. 2023; 7(11):e10838.
PMID: 38025034 PMC: 10652175. DOI: 10.1002/jbm4.10838.
Misof B, Blouin S, Andrade V, Roschger P, Borba V, Hartmann M J Musculoskelet Neuronal Interact. 2022; 22(3):305-315.
PMID: 36046986 PMC: 9438521.
Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus.
Palui R, Pramanik S, Mondal S, Ray S World J Diabetes. 2021; 12(6):706-729.
PMID: 34168723 PMC: 8192255. DOI: 10.4239/wjd.v12.i6.706.
Traditional and Non-traditional Risk Factors for Osteoporosis in CKD.
Jorgensen H, David K, Salam S, Evenepoel P Calcif Tissue Int. 2021; 108(4):496-511.
PMID: 33586002 DOI: 10.1007/s00223-020-00786-0.